Open Scanner

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Allakos Inc

ALLK
Current price
1.07 USD +0.02 USD (+1.90%)
Last closed 1.06 USD
Sector Healthcare
Industry Biotechnology
Exchange NASDAQ
Capitalization 97 540 144 USD
Yield for 12 month -74.64 %
1Y
3Y
5Y
10Y
15Y
ALLK
21.11.2021 - 28.11.2021

Allakos Inc., a clinical stage biotechnology company, develops therapeutics that target immunomodulatory receptors present on immune effector cells in allergy, inflammatory, and proliferative diseases in the United States. The company's lead product candidate is AK006, which in a Phase I clinical trial for the treatment of chronic spontaneous urticaria (CSU) and other indications. The company was incorporated in 2012 and is headquartered in San Carlos, California. Address: 825 Industrial Road, San Carlos, CA, United States, 94070

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

2.9 USD

P/E ratio

Dividend Yield

Current Year

Last Year

Current Quarter

Last Quarter

Current Year

-6 141 000 USD

Last Year

-9 975 000 USD

Current Quarter

-1 547 000 USD

Last Quarter

-1 549 000 USD

Key Figures ALLK

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA -189 915 008 USD
Operating Margin TTM
PE Ratio
Return On Assets TTM -38.9 %
PEG Ratio
Return On Equity TTM -77.5 %
Wall Street Target Price 2.9 USD
Revenue TTM
Book Value 1.92 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY
Dividend Yield
Gross Profit TTM
Earnings Share -2.14 USD
Diluted Eps TTM -2.14 USD
Most Recent Quarter IV 2023
Quarterly Earnings Growth YOY
Profit Margin

Dividend Analytics ALLK

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

Dividend History ALLK

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield
Last Split Factor
Payout Ratio
Last Split Date
Dividend Date

Stock Valuation ALLK

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE
Enterprise Value Revenue
Price Sales TTM
Enterprise Value EBITDA 0.1674
Price Book MRQ 0.5778

Financials ALLK

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators ALLK

For 52 weeks

1 USD 5.64 USD
50 Day MA 1.31 USD
Shares Short Prior Month 5 601 439
200 Day MA 2.48 USD
Short Ratio 8.67
Shares Short 5 557 841
Short Percent 8.29 %

Dynamics of changes in the value of assets

Stocks


MSFT

MSFT

399.12 USD Microsoft Corporation -4.91 (-1.22%)
Detailed analytics

ETF funds


M

MDAXEX

207.85 CHF iShares MDAX UCITS ETF (DE) 0 (0%)
Detailed analytics

Metals


Gold

2175.88 USD Gold +5.94 (+0.27%)
Detailed analytics